Cargando…

The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment

The kidney local microenvironment (KLM) plays a critical role in the pathogenesis of kidney fibrosis. However, the composition and regulation of a fibrotic KLM remain unclear. Through a multidisciplinary approach, we investigated the roles of the hepatocyte growth factor/c-met signaling pathway in r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Haiyan, Gui, Yuan, Liu, Silvia, Wang, Yuanyuan, Bastacky, Sheldon Ira, Qiao, Yi, Zhang, Rong, Bonin, Christopher, Hargis, Geneva, Yu, Yanbao, Kreutzer, Donald L., Biswas, Partha Sarathi, Zhou, Yanjiao, Wang, Yanlin, Tian, Xiao-Jun, Liu, Youhua, Zhou, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479790/ https://www.ncbi.nlm.nih.gov/pubmed/34622165 http://dx.doi.org/10.1016/j.isci.2021.103112

Ejemplares similares

Serum integrative omics reveals the landscape of human diabetic kidney disease
por: Liu, Shijia, et al.
Publicado: (2021)

Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury
por: Zhou, Dong, et al.
Publicado: (2013)

Diabetic kidney diseases revisited: A new perspective for a new era
por: Fu, Haiyan, et al.
Publicado: (2019)

Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling
por: Mungunsukh, Ognoon, et al.
Publicado: (2014)

Arsenicosis: Is it a Protective or Predisposing Factor for Mental Illness?
por: Sen, Devosri, et al.
Publicado: (2012)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Arsenic-Induced Injury of Mouse Hepatocytes through Lysosome and Mitochondria: An In Vitro Study
por: Santra, Amal, et al.
Publicado: (2022)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET
por: SHENG, XIU-JIE, et al.
Publicado: (2014)

Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells
por: Koenen, Maria Teresa, et al.
Publicado: (2022)

Atypical presentation of atypical mycobacteria in atypical diabetes
por: Biswas, Sugata Narayan, et al.
Publicado: (2016)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
por: Liu, Li, et al.
Publicado: (2021)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
por: Lee, Young-Sun, et al.
Publicado: (2017)

Assessment of hepatic function employing hepatocyte specific contrast agent concentrations to multifactorially evaluate fibrotic remodeling
por: Breit, Hanns-Christian, et al.
Publicado: (2023)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes
por: Bai, Li, et al.
Publicado: (2017)

Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair
por: Wang, Peng, et al.
Publicado: (2022)

Epidemiology and risk factors for multidrug-resistant bacteria in critically ill patients with liver disease
por: Choudhuri, Anirban Hom, et al.
Publicado: (2018)

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2021)

Safety and efficacy of convalescent plasma as a therapy for SARS-CoV-2: A systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2022)

Sulfated Alginate Reduces Pericapsular Fibrotic Overgrowth on Encapsulated cGMP-Compliant hPSC-Hepatocytes in Mice
por: Syanda, Adam M., et al.
Publicado: (2022)

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Publicado: (1995)

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
por: Parikh, Rahul A, et al.
Publicado: (2014)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”
por: Ricci, Giulia
Publicado: (2015)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
por: Rothenberger, Natalie J., et al.
Publicado: (2017)

Role of Ferroptosis in Fibrotic Diseases
por: Zhou, Jian, et al.
Publicado: (2022)

Development and characterization of anti-fibrotic natural compound similars with improved effectivity
por: Kreutzer, Fabian Philipp, et al.
Publicado: (2022)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

IL-17 Receptor Signaling Negatively Regulates the Development of Tubulointerstitial Fibrosis in the Kidney
por: Ramani, Kritika, et al.
Publicado: (2018)

Scleroderma Renal Crisis: A Pathology Perspective
por: Batal, Ibrahim, et al.
Publicado: (2010)

A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met
por: Basilico, Cristina, et al.
Publicado: (2008)

Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?
por: Wang, Xiangdong, et al.
Publicado: (2010)

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression
por: NOGUCHI, EIICHIRO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g4pa3c8lg0c7u9r24vbi5ts24v